Eye Institute Of thrace
Alexandroupoli, Evros, 68100, Greece
NCT Number: NCT02558218
Primary objective of the study is the assessment of the patients' discomfort and ocular redness following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.
Looking for future studies?
Notify Me55 year–65 year
All sexes
Interventional
Not applicable
Alexandroupoli, Evros, 68100, Greece
Participants will be recruited from the Cataract Service of the University Hospital of Alexandroupolis (UHA) in a consecutive-if-eligible basis. By means of a custom computer randomization program all participants will randomly populate either study group (who will receive Systane Ultra as additional postoperative treatment) and control group (who will receive standard postoperative treatment).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Further to standard medication (tobradex quid for 20 days), participants were administered Systane Ultra quid for 2 months
Other names: Administration of Systane Ultra (Alcon)
Standard medication (tobradex quid for 20 days)
Other names: Standard Medication
Time frame: 1 month postoperatively
Foreign body sensation will be assessed by a direct 5-scale, Likert type question that will be addressed to the participants at the 30th postoperative day
Time frame: 7 days postoperatively
Ocular redness will be assessed by means of a validated photographic chart
Time frame: 1 month postoperatively
Corneal Sensitivity will be assessed by Cochet-Bonnet esthesiometer at the 7th and 30th postoperative day
Democritus University of Thrace
Other
Postoperative Discomfort and Ocular Redness Following Phacoemulsification and Intraocular Lens Implantation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735000
Age Related Cataract, Cataract
Peshawar, KPK, Pakistan
View Trial DetailsNCT07605260
Cataract, Eye Diseases
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT06428955
Cataract, Eye Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT06111222
Cataract, Eye Diseases
Heidelberg, Germany
View Trial Details